This article is more than 5 years old. Information may no longer be current.

FDA clears microperimetry as part of Optos OCT SLO

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Optos has received 510(k) clearance from the U.S. Food and Drug Administration to include microperimetry as part of its OCT SLO device, according to a company news release.

With the clearance, the device is the only one on the market to offer structural optical coherence tomography and functional microperimetry testing, the release said.

Microperimetry testing will allow physicians to better assess retinal sensitivity, which can help determine the association between structural pathology and related visual functional defects, according to the release.

The microperimetry test is designed to run concurrently with a high-speed confocal scanning laser ophthalmoscope to deliver real-time tracking of retinal vessels.